Physicians' Trust in the FDA's Use of Product-Specific Pathways for Generic Drug Approval.

ABSTRACT:

Background

Generic drugs are cost-effective versions of brand-name drugs approved by the Food and Drug Administration (FDA) following proof of pharmaceutical equivalence and bioequivalence. Generic drugs are widely prescribed by physicians, although there is disagreement over the clinical comparability of generic drugs to brand-name drugs within the physician community. The objective of this survey was to assess physicians' perceptions of generic drugs and the generic drug approval process.

Methods and findings

A survey was administered to a national sample of primary care internists and specialists between August 2014 and January 2015. In total, 1,152 physicians comprising of internists with no reported specialty certification and those with specialty certification in hemat

SUBMITTER: Kesselheim AS 

PROVIDER: S-EPMC5074566 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature